Exploring the association of glyceraldehyde-3-phosphate dehydrogenase gene and Alzheimer disease

Neurology

Volumn 67, Issue 1, 2006, Pages 64-68

  Lin, P I ^a   Martin, E R ^a   Bronson, P G ^a   Browning Large, C ^a   Small, G W ^b   Schmechel, D E ^a   Welsh Bohmer, K A ^a   Haines, J L ^c   Gilbert, J R ^a   Pericak Vance, M A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 12P; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FAMILY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOGENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME 12; COMPARATIVE STUDY; FAMILY HEALTH; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 12; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33746783852     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000223438.90113.4e     Document Type: Article

References (42)

1. Li Y, Nowotny P, Holmans P, et al. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci USA 2004 101:15688-15693.
2. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population - prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-1122.
3. Breitner JC, Silverman JM, Mohs RC, Davis KL. Familial aggregation in Alzheimer's disease: comparison of risk among first degree relatives of early- and late-onset cases, and among male and female relatives in a successive generation. Neurology 1988;38:207-212.
4. Breitner JCS, Welsh-Bohmer KA, Gau BA, et al. Alzheimer's Disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans: III. Detection of cases, longitudinal results and observations on twin concordance. Arch Neurol 1995;52:763-771.
5. Gatz M, Pedersen NL. Use of twin samples to estimate the heritability of Alzheimer's disease: a methodological note. Alzheimers Research 1996;2:229-232.
6. Pericak-Vance MA, Bebout JL, Gaskell PC, et al. Linkage studies in familial Alzheimer's disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-1050.
7. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
8. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E, epsilon 4, allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosome region. Hum Mol Genet 1994;3:569-574.
9. Ashford JW. APOE genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci 2004;23:157-165.
10. Farrer LA, Bowirrat A, Friedland RP, Waraska K, Korczyn AD, Baldwin CT. Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum Mol Genet 2003;12:415-422.
11. Blacker D, Bertram L, Saunders AJ, et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 2003;12:23-32.
12. Kehoe P, Wavrant-De Vrieze F, Crook R, et al. A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 1999;8:237-245.
13. Pericak-Vance MA, Grubber J, Bailey LR, et al. Identification of novel genes in late-onset Alzheimer disease. Exp Gerontol 2000;35:1343-1352.
14. Myers A, Wavrant De-Vrieze F, Holmans P, et al. Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 2002;114:235-244.
15. Myers A, Holmans P, Marshall H, et al. Susceptibility locus for Alzheimer's disease on chromosome 10. Science 2000;290:2304-2305.
16. Pericak-Vance MA, Bass MP, Yamaoka LH, et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997;278:1237-1241.
17. Pericak-Vance MA, Bass ML, Yamaoka LH, et al. Complete genomic screen in late-onset familial Alzheimer's disease. Neurobiol Aging 1998; 19(suppl 1):S39-S42.
18. Rogaeva E, Premkumar S, Song Y, et al. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 1998;280:614-618.
19. Scott WK, Grubber JM, Conneally PM, et al. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am J Hum Genet 2000;66:922-932.
20. Scott WK, Grubber JM, Abou-donia SM, et al. Fine mapping and two-locus maximum lod score analysis in chromosome 12-linked late-onset familial Alzheimer disease (AD). Am J Hum Genet 1998;63:A44. Abstract.
21. Schulze H, Schuler A, Stuber D, Dobeli H, Langen H, Huber G. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-amyloid precursor protein. J Neurochem 1993;60:1915-1922.
22. Tsuchiya K, Tajima H, Yamada M, et al. Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis. Life Sci 2004;74:3245-3258.
23. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 1995;15:3775-3787.
24. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
25. Hardy J, Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science 1998;282:1075-1079.
26. Ramirez VD, Kipp JL, Joe I. Estradiol, in the CNS, targets several physiologically relevant membrane-associated proteins. Brain Res Brain Res Rev 2001;37:141-152.
27. Carlile GW, Chalmers-Redman RM, Tatton NA, Pong A, Borden KE, Tatton WG. Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol Pharmacol 2000;57:2-12.
28. Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 1986;315:1241-1245.
29. Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group. Dementia 1996;7:293-303.
30. McKhann G, Drachman D, Folstein M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
31. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
32. Oliveira SA, Scott WK, Nance MA, et al. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol 2003;60:975-980.
33. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
34. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
35. Abecasis GR, Cookson WO. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 2000;16:182-183.
36. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955;11:375-386.
37. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-434.
38. Lake SL, Lyon H, Tantisira K, et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003;55:56-65.
39. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000;67:146-154.
40. Martin ER, Bass MP, Hauser ER, Kaplan NL. Accounting for linkage in family-based tests of association with missing parental genotypes. Am J Hum Genet 2003;73:1016-1026.
41. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150.
42. Maraganore DM. Blood is thicker than water: the strengths of family-based case-control studies. Neurology 2005;64:408-409.